Heming Wang
Assistant Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (11)
Introduction: Circadian misalignment is an emerging risk factor for poor cardiovascular health, and chronotype may reflect underlying circadian processes. While previous conventional observational studies have reported adverse associations between evening chronotype and individual cardiovascular risk factors, Mendelian randomization (MR) may provide further insights into the role of chronotype in overall cardiovascular health, as measured by the American Heart Association's Life's Essential 8 (LE8; a composite lifestyle and cardiovascular health score ranging from 0 to 100; higher scores indicate better health). Methods: We conducted both observational cross-sectional and one-sample MR analyses among 317,730 UK Biobank (UKB) participants of White ethnicity. Chronotype was self-reported and modeled on a five-level continuous scale from "definitely evening" to "definitely morning". A polygenic risk score including 341 morning chronotype-associated SNPs from a UKB GWAS served as the MR instrument. Two-stage least-squares regression estimated difference in LE8 per one-unit increment in chronotype towards more morningness, adjusting for age, sex, assessment center, genotyping batch, and 40 genetic principal components. To mitigate potential winner's curse bias in UKB due to inflated GWAS estimates, we replicated the analysis in 13,396 White women in the Nurses' Health Study II (NHSII). Results: In UKB, the multivariable-adjusted difference in LE8 score for each one-unit increment toward more morningness was 0.75-points higher (95% CI: 0.72, 0.78; P<0.001) in observational analysis and a 0.75-points higher (95% CI: 0.55, 0.96; P<0.001) in MR analysis. MR results were similar for men and women (P-heterogeneity = 0.70). In NHSII, while both estimates were positive, increased morningness was associated with higher overall LE8 scores in observational analysis (β = 1.57, 95% CI: 1.40, 1.75; P<0.001), but not in MR analysis (β = 0.89, 95% CI: -0.67, 2.44; P = 0.26), although the MR association became significant when the score was based only on behavioral components (β = 2.04; 95% CI: 0.43, 3.65; p = 0.0130). Further, morning chronotype was consistently associated with healthy diet across observational and MR analyses in both cohorts. Conclusions: Our findings suggest a modest causal relationship between morning chronotype and better cardiovascular health profiles, particularly diet quality, although replication in other populations remains necessary.
Year:
2026
Background Obstructive sleep apnea (OSA) is associated with a wide range of comorbidities, but large-scale phenome-wide analyses in clinical biobanks remain under-reported. In this study, we identified common comorbidities enriched in patients with OSA, tested the temporality of these associations, and analyzed relevant associations with summary sleep recording data. Methods 48,251 participants with OSA in the Mass General Brigham healthcare system were identified using a natural language processing phenotyping algorithm and/or evidence of an elevated apnea-hypopnea index (AHI). Controls were matched (2:1) on demographics, body mass index (BMI), and healthcare utilization. Associations with 358 incident and 563 cross-sectional diseases were tested using Modified Poisson regression, adjusting for covariates. Sensitivity analyses examined timing by binning data in years relative to the first OSA diagnosis. Selected laboratory results were obtained based on associated diseases. Associated diseases were tested with sleep recording statistics (n ≤18,348). Findings 179 incident and 421 cross-sectional diseases were associated with OSA at Bonferroni significance. 37 diseases had Bonferroni-significant sex interactions. Several associations were significant years before the first recorded OSA diagnosis. Four red blood cell laboratory measures were significant ten years prior to the first diagnosis. One incident and 47 cross-sectional diseases were associated with the AHI and/or chronic hypoxemia. Interpretation Obstructive sleep apnea is associated with enrichment of hundreds of diseases, several of which are supported by orthogonal polysomnographic evidence. Leveraging early signs of OSA in clinical data may help to identify at-risk patients. Funding National Institutes of Health and the American Academy of Sleep Medicine Foundation.
Year:
2025
Introduction: Individuals with an evening chronotype often experience circadian misalignment, which may disrupt health behaviors and circadian regulation of cardiometabolic functions such as blood pressure. However, the associations of chronotype with modifiable cardiovascular disease (CVD) risk factors and incident CVD are not fully understood. Methods: We conducted a prospective study in 322,777 UK Biobank participants aged 39-74 years who were free of known CVD (2006-2010). Chronotype was self-reported using a single representative question from the Morningness-Eveningness Questionnaire. The Life’s Essential 8 (LE8) score was calculated based on 8 modifiable CVD risk factors, and ranged from 0 to 100 with higher scores indicating better cardiovascular health. Incident CVD was defined as first myocardial infarction (MI) or stroke leading to hospitalization or death, identified via validated algorithms. Cox proportional hazards models estimated the association between chronotype and CVD risk, adjusted for socio-demographics, shift work, and family history of CVD. Under the causal mediation framework, we evaluated the role of LE8 in the association between chronotype and CVD risk by decomposing the total effect into natural direct effect (i.e., independent of LE8) and natural indirect effect (i.e., mediated by LE8; NIE). Results: Participants (mean age: 57) with a “definite evening” chronotype (8% of the total sample) were 79% more likely to have an overall poor LE8 score (<50 points) compared to “intermediate” type (prevalence ratio 95% CI: 1.72 - 1.85). Over a median of 13.2 years of follow-up, there were 17,584 incident CVD events (11,091 MI; 7,214 stroke). The hazard ratio (HR) for total CVD was 1.03 (0.99 - 1.07) for the “definite morning” and 1.16 (1.10 - 1.22) for “definite evening” compared with “intermediate” chronotype (P-trend: 0.10). LE8 explained 74% of the association between evening chronotype and CVD (NIE comparing “definite evening” to “intermediate: 1.11; 95% CI: 1.09, 1.13). Findings were similar when MI and stroke were examined individually. Conclusions: Compared to intermediate chronotype, evening chronotype was associated with modestly higher CVD risk, which was mainly explained by overall poorer cardiovascular health. These results suggest that individuals with evening chronotype may particularly benefit from interventions targeting CVD risk factors.
Year:
2025
Obstructive sleep apnea (OSA) is a multifactorial sleep disorder characterized by a strong genetic basis. Excessive daytime sleepiness (EDS) is a symptom that is reported by a subset of OSA patients, persisting even after treatment with continuous positive airway pressure (CPAP). It is recognized as a clinical subtype underlying OSA carrying alarming heightened cardiovascular risk. Thus, conceptualizing EDS as an exposure variable, we sought to investigate EDS’s influence on genetic variation linked to apnea-hypopnea index (AHI), a diagnostic measure of OSA severity. This study serves as the first large-scale genome-wide gene x environment interaction analysis for AHI, investigating the interplay between its genetic markers and EDS across and within specific sex. Our work pools together whole genome sequencing data from seven cohorts, enabling a diverse dataset (four population backgrounds) of over 11,500 samples. Among the total 16 discovered genetic targets with interaction evidence with EDS, eight are previously unreported for OSA, including CCDC3 , MARCHF1 , and MED31 identified in all sexes; TMEM26 , CPSF4L , and PI4K2B identified in males; and RAP1GAP and YY1 identified in females. We discuss connections to insulin resistance, thiamine deficiency, and resveratrol use that may be worthy of therapeutic consideration for excessively sleepy OSA patients.
Year:
2024
Irregular sleep duration may disrupt circadian rhythms and contribute to metabolic, behavioral, and mood changes, potentially increasing the risk for obesity. However, quantitative data on the relationship between sleep duration irregularity and weight change are lacking. In this prospective study, we analyzed data from 10,572 participants (mean age: 63 years) in the UK Biobank who wore accelerometers for a week between 2013-2015 and had two body mass index (BMI; kg/m 2 ) measurements on average 2.5 years apart. Irregular sleep duration was assessed by the within-person standard deviation (SD) of 7-night accelerometer-measured sleep duration. Participants with sleep duration SD >60 minutes versus ≤30 minutes had 0.24 kg/m 2 (95% CI: 0.08, 0.40) higher BMI change (kg/m 2 ), standardized to three-year intervals, and 80% (95% CI: 1.28, 2.52) higher risk for incident obesity, after adjusting for sociodemographic factors, shift work, and baseline BMI or follow-up period (p-trend<0.02 for both). These associations remained consistent after adjusting for lifestyle, comorbidities, and other sleep factors, including sleep duration. Age, sex, baseline BMI, and genetic predisposition to higher BMI (measured with a polygenic risk score) did not appear to modify the association. Since irregular sleep duration is common, trials of interventions targeting sleep irregularity might lead to new public health strategies that tackle obesity.
Year:
2024
Obstructive sleep apnea (OSA) is a multifactorial sleep disorder characterized by a strong genetic basis. Excessive daytime sleepiness (EDS) is a symptom that is reported by a subset of OSA patients, persisting even after treatment with continuous positive airway pressure (CPAP). It is recognized as a clinical subtype underlying OSA carrying alarming heightened cardiovascular risk. Thus, conceptualizing EDS as an exposure variable, we sought to investigate EDS’s influence on genetic variation linked to apnea-hypopnea index (AHI), a diagnostic measure of OSA severity. This study serves as the first large-scale genome-wide gene x environment interaction analysis for AHI, investigating the interplay between its genetic markers and EDS across and within specific sex. Our work pools together whole genome sequencing data from seven cohorts, enabling a diverse dataset (four population backgrounds) of over 11,500 samples. Among the total 16 discovered genetic targets with interaction evidence with EDS, eight are previously unreported for OSA, including CCDC3 , MARCHF1 , and MED31 identified in all sexes; TMEM26 , CPSF4L , and PI4K2B identified in males; and RAP1GAP and YY1 identified in females. We discuss connections to insulin resistance, thiamine deficiency, and resveratrol use that may be worthy of therapeutic consideration for excessively sleepy OSA patients.
Year:
2024
Background Obstructive sleep apnea (OSA) is a heterogeneous disease, with obesity a significant risk factor via increased airway collapsibility, reduced lung volumes, and possibly body fat distribution. Methods Using race/ethnic diverse samples from the Million Veteran Program, FinnGen, TOPMed, All of Us (AoU), Geisinger’s MyCode, MGB Biobank, and the Human Phenotype Project (HPP), we developed, selected, and assessed polygenic scores (PGSs) for OSA, relying on genome-wide association studies both adjusted and unadjusted for BMI: BMIadjOSA- and BMIunadjOSA-PGS. We tested their associations with CVD in AoU. Results Adjusted odds ratios (ORs) for OSA per 1 standard deviation of the PGSs ranged from 1.38 to 2.75. The associations of BMIadjOSA- and BMIunadjOSA-PGSs with CVD outcomes in AoU shared both common and distinct patterns. For example, BMIunadjOSA-PGS was associated with type 2 diabetes, heart failure, and coronary artery disease, but the associations of BMIadjOSA-PGS with these outcomes were statistically insignificant with estimated OR close to 1. In contrast, both BMIadjOSA- and BMIunadjOSA-PGSs were associated with hypertension and stroke. Sex stratified analyses revealed that BMIadjOSA-PGS association with hypertension was driven by data from OR=1.1, p-value=0.002, OR=1.01 p-value=0.2 in males). OSA PGSs were also associated with dual-energy X-ray absorptiometry (DXA) body fat measures with some sex-specific associations. Conclusions Distinct components of OSA genetic risk are related to obesity and body fat distribution, and may influence clinical outcomes. These may explain differing OSA risks and associations with cardiometabolic morbidities between sex groups.
Year:
2024
Background Excessive daytime sleepiness (EDS) is a complex sleep problem that affects approximately 33% of the United States population. Although EDS usually occurs in conjunction with insufficient sleep, and other sleep and circadian disorders, recent studies have shown unique genetic markers and metabolic pathways underlying EDS. Here, we aimed to further elucidate the biological profile of EDS using large scale single- and pathway-level metabolomics analyses. Methods Metabolomics data were available for 877 metabolites in 6,071 individuals from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and EDS was assessed using the Epworth Sleepiness Scale (ESS) questionnaire. We performed linear regression for each metabolite on continuous ESS, adjusting for demographic, lifestyle, and physiological confounders, and in sex specific groups. Subsequently, gaussian graphical modelling was performed coupled with pathway and enrichment analyses to generate a holistic interactive network of the metabolomic profile of EDS associations. Findings We identified seven metabolites belonging to steroids, sphingomyelin, and long chain fatty acids sub-pathways in the primary model associated with EDS, and an additional three metabolites in the male-specific analysis. The identified metabolites particularly played a role in steroid hormone biosynthesis. Interpretation Our findings indicate that an EDS metabolomic profile is characterized by endogenous and dietary metabolites within the steroid hormone biosynthesis pathway, with some pathways that differ by sex. Our findings identify potential pathways to target for addressing the causes or consequences of EDS and related sleep disorders. Funding Details regarding funding supporting this work and all studies involved are provided in the acknowledgments section. Research in context Evidence before this study There is a growing recognition of the paramount importance of sleep on health and cardiometabolic disease. Excessive daytime sleepiness (EDS), one of the key common sleep treatment targets, has been linked to increased risk of mortality, hypertension, cardiovascular disease, car accidents as well as decrease in life quality, and productivity. Despite its impact on health, much remains unknown about the biological mechanisms of EDS and if those mechanisms are independent from other sleep disorders. Recent genetic evidence that shows that EDS is associated with specific genetic biomarkers supports the need to further study the underlying biology of EDS. Added value of this study Here, we used measurements of metabolites, the products and by-products of metabolism to identify the metabolomic profile of EDS. Metabolites are produced by the biological reactions within the body via proteins—themselves products of genes—and by the breakdown of external sources such as nutritional intake and breathing air pollutants. Therefore, metabolomics enables study of the effects of nutrition, environmental exposures, and genetics. In this study we aimed to identify the metabolites that were associated with excessive daytime sleepiness. Additionally, we mapped these metabolites into a publicly available online biological network of human metabolism pathways to obtain an understanding of our findings on a larger scale. Implications of all the available evidence Identifying the metabolites and pathways related to daytime sleepiness provides insights into the biological mechanisms of EDS and suggests future research opportunities to identify targets for prevention, prediction, and treatments for EDS and potentially other sleep disorders coupled with sleepiness. In this study we found 7 such metabolites—some endogenously synthesised and some obtained from dietary sources—associated with EDS. The network analysis implicated the steroid hormone biosynthesis pathway as a shared pathway underlying those metabolites, and identified linkages to key metabolites related to sleep: melatonin and cortisol metaboli
Year:
2024
Objective We sought to evaluate whether obstructive sleep apnea (OSA), and other sleep disorders, increase genetic risk of developing diabetes mellitus (DM). Research Design and Methods Using GWAS summary statistics from the DIAGRAM consortium and Million Veteran Program, we developed multi-ancestry Type 2 Diabetes (T2D) polygenic risk scores (T2D-PRSs) useful in admixed Hispanic/Latino individuals. We estimated the association of the T2D-PRS with cross-sectional and incident DM in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). We conducted a mediation analysis with T2D-PRSs as an exposure, incident DM as an outcome, and OSA as a mediator. Additionally, we performed Mendelian randomization (MR) analysis to assess the causal relationship between T2D and OSA. Results Of 12,342 HCHS/SOL participants, at baseline, 48.4% were normoglycemic, 36.6% were hyperglycemic, and 15% had diabetes, and 50.9% identified as female. Mean age was 41.5, and mean BMI was 29.4. T2D-PRSs was strongly associated with baseline DM and with incident DM. At baseline, a 1 SD increase in the primary T2D-PRS had DM adjusted odds ratio (OR) = 2.67, 95% CI [2.40; 2.97] and a higher incident DM rate (incident rate ratio (IRR) = 2.02, 95% CI [1.75; 2.33]). In a stratified analysis based on OSA severity categories the associations were stronger in individuals with mild OSA compared to those with moderate to severe OSA. Mediation analysis suggested that OSA mediates the T2D-PRS association with DM. In two-sample MR analysis, T2D-PRS had a causal effect on OSA, OR = 1.03, 95% CI [1.01; 1.05], and OSA had a causal effect on T2D, with OR = 2.34, 95% CI [1.59; 3.44]. Conclusions OSA likely mediates genetic effects on T2D.
Year:
2024
Background Emerging evidence supports a link between circadian disruption as measured by higher night-to-night variation in sleep duration and increased risk of cardiovascular disease (CVD). It remains unclear whether this association varies by CVD types or may be modified by average sleep duration and genetic risk for CVD. Methods Our prospective analysis included 86,219 UK Biobank participants who were free from CVD when completing 7 days of accelerometer measurement in 2013-2016. Sleep irregularity was evaluated by the standard deviation (SD) of accelerometer-measured sleep duration over 7 days. Incident major CVD events, defined as fatal or nonfatal myocardial infarction (MI) and stroke, were identified through linkage to Hospital Episode Statistics data until May 31, 2022. Multivariable-adjusted Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CIs for associations of sleep duration SD with risk for major CVD events overall and for MI and stroke separately. Results We documented 2,310 incident cases of major CVD events (MI: 1,183, stroke: 1,175) over 636,258 person-years of follow-up. After adjusting for sociodemographic factors and family history of CVD, the HR (95% CI) associated with a 1-hour increase in sleep duration SD was 1.19 (1.10, 1.27) for CVD (p-trend 8 hours (p-interaction=0.006) Conclusions Higher night-to-night variation in accelerometer-measured sleep duration was associated with consistently higher risks for major CVD events. The association did not seem to be modified by genetic risk for CVD and was more pronounced in long sleepers.
Year:
2024
Year:
2024
Collaborators (52)
Xiaofeng Zhu
Professor
Case Western Reserve University
Harold Snieder
Scientific Staff
University Medical Center Groningen
Amy Bentley
National Human Genome Research Institute
Cristina Menni
King’s College London
Nicholas Wareham
Director
University of Cambridge
H. Lester Kirchner
Professor and Chair
Geisinger Medical Center
Joseph McCormick
James H. Steele Professor
-
Laura Raffield
Assistant Professor
University of North Carolina at Chapel Hill
Sina Kianersi
Harvard University
Han Chen
Professor
NYU School of Medicine
Vilmundur Gudnason
Professor
University of Iceland
Bertha Hidalgo
Associate Professor and Associate Dean
University of Alabama, Tuscaloosa
Simon R. Cox
Personal Chair of Brain and Cognitive Ageing
University of Edinburgh
Jennifer Ann Smith
Professor
University of Michigan
Sarah Harris
University of Edinburgh
Ching-Ti Liu
Boston University
Ko Willems van Dijk
Professor
Leiden University Medical Center
massimo mangino
Honorary Senior Lecturer
King’s College London
Ilja Nolte
Senior Researcher of Statistical Genetics and Genetic Epidemiology
University Medical Center Groningen
Heather M Highland
University of North Carolina at Chapel Hill
Marcus Dörr
University Medicine Greifswald
Paul de Vries
Assistant Professor
The University of Texas Health Science Center at Houston School of Public Health
Lisa de las Fuentes
Professor of Medicine and Biostatistics
Washington University School of Medicine
Farhad R. Nezami
Lead Investigator and Faculty Member
Brigham and Women's Hospital
Martin Rutter
Professor of Cardiometabolic Medicine
The University of Manchester
Ali Azarbarzin
Harvard University
Iris M. Heid
University of Regensburg
Rodney Scott
Prof. of Medical Genetics
University of Newcastle Australia
Myriam Fornage
-
Changwei Li
Associate Professor
University of Texas Southwestern Medical Center
Scott Sands
Associate Physiologist
Brigham and Women's Hospital
Mary Feitosa
Associate Professor
Washington University School of Medicine
Debbie A Lawlor
Academic , Professor of Epidemiology, MRC Investigator and BHF Chair
University of Bristol
Sami Heikkinen
Research Director
University of Eastern Finland
Peter Y Liu
University of California
Kari North
Professor
University of North Carolina at Chapel Hill
Kisung Nam
Seoul National University
Michael Province
Professor, Head Division of Statistical Genomics
Washington University in St. Louis
Uwe Völker
Professor, Head of Department
Universitätsmedizin Greifswald
Quan Sun
Research Assistant Professor
University of Pennsylvania
John Attia
University of Newcastle Australia
Kathryn Rexrode
Division Chief; Associate Professor of Medicine
Brigham and Women's Hospital
Nicholette Allred
Wake Forest Baptist Medical Center
Mariaelisa Graff
Assistant Professor
University of North Carolina
Albert Vernon Smith
University of Michigan
Brian Cade
Investigator
Brigham and Women's Hospital
Anne Justice
Associate Professor
Geisinger Health
Terho Lehtimäki
University of Tampere
SINA A. GHARIB
University of Washington
Jian'an Luan
University of Cambridge
Tianyi Huang
Tenure-Track Investigator
National Institute on Aging
Raymond Noordam
Assistant Professor
Leiden University Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.